Repozytorium

Autor publikacji Y. Konishi

2006

Drug evolution concept in drug design: 2. Chimera method.

Kluczyk Alicja, Kiyota T., Lazar C., Popek Tomasz, Roman G., Konishi Y.

2004

Drug evolution concept in drug design: 1. Hybridization method.

Lazar C., Kluczyk Alicja, Kiyota T., Konishi Y.

2002

Drug evolution: p-aminobenzoic acid as a building block.

Kluczyk Alicja, Popek Tomasz, Kiyota T., de Macedo P., Stefanowicz Piotr, Lazar C., Konishi Y.

2001

Bivalent thrombin inhibitors.

Konishi Y., Szewczuk Zbigniew, Tsuda Y.

2001

Taxines from the needles ofTaxus wallichiana.

Prasain J. K., Stefanowicz Piotr, Kiyota T., Habeichi F., Konishi Y.

2000

Bivalent thrombin inhibitors.

Konishi Y., Szewczuk Zbigniew, Tsuda Y.

2000

Monitoring glycation of lysozyme by electrospray ionization mass spectrometry.

Yeboah K. F., Alli I., Yaylayan V. A., Konishi Y., Stefanowicz Piotr

1995

Interactions of hirudin-based inhibitor with thrombin: critical role of the IleH459 side chain of the inhibitor.

Tsuda Y., Szewczuk Zbigniew, Wang J., Yue S. Y., Purisima E. O., Konishi Y.

1993
1993

Chemical compensation in macromolecular bridge-binding to thrombin.

Hopfner K.-P., Ayala Y., Szewczuk Zbigniew, Konishi Y., Di Cera E.

1993

Design of a linker for trivalent thrombin inhibitors : interaction of the main chain of the linker with thrombin.

Szewczuk Zbigniew, Gibbs B. F., Yue S. Y., Purisima E. O., Zdanov A., Cygler Miroslaw, Konishi Y.

1992

Conformationally restricted thrombin inhibitors resistant to proteolytic digestion.

Szewczuk Zbigniew, Gibbs B. F., Yue S. Y., Purisima E. O., Konishi Y.

1992

Synthetic bifunctional thrombin inhibitors : linker design.

Szewczuk Zbigniew, Yue S. Y., Konishi Y.

Drug evolution : drug design at hot spots.

Konishi Y., Cho S. J., Kluczyk Alicja, Kiyota T., Lazar C., de Macedo P.